[Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
Tomioka
H
H
Department of Microbiology and Immunology, Shimane Medical University.
Sato
K
K
Saito
H
H
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular / Q000494:pharmacology* / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D024841:Fluoroquinolones; D006801:Humans; D018942:Macrolides; D051379:Mice; D015269:Mycobacterium avium Complex / Q000187:drug effects*; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D024841:Fluoroquinolones; D018942:Macrolides